Visualized abnormalities include conditions such as sun damage, rosacea, melasma, telangiectasia and others.For the clinical trial in this example the vasodilator composition contained water, arginine HCl, urea, glycerin, hydroxyethylcellulose, allantoin, methylisothiazolinone.